CIK 0001639691 · Large accelerated filer
LivaNova PLC
Sign in to watch- Ticker
- LIVN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981268150
- Phone
- 4402033250660
- Business address
- 5220 VALIANT COURT, GLOUCESTER BUSINESS PARK, GLOUCESTER, United Kingdom
- Former names
- Sand Holdco Plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $819,115
- in 4 filings, $227K under 10b5-1 plans
Net −$819,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Enxing Seng Stacy Director | Shares withheld for taxes | −486 | $79.70 | $39K | 15,307 |
| 2026-06-15 | Enxing Seng Stacy Director | Option exercise · Restricted Stock Units | −4,042 | 0 | ||
| 2026-06-15 | Enxing Seng Stacy Director | Grant or award · Restricted Stock Units | +2,383 | 2,383 | ||
| 2026-06-15 | Story Brooke Director | Option exercise | +4,042 | 10,274 | ||
| 2026-06-15 | Story Brooke Director | Shares withheld for taxes | −486 | $79.70 | $39K | 9,788 |
| 2026-06-15 | Story Brooke Director | Option exercise · Restricted Stock Units | −4,042 | 0 | ||
| 2026-06-15 | Story Brooke Director | Grant or award · Restricted Stock Units | +2,383 | 2,383 | ||
| 2026-06-15 | Zurbay Donald Director | Option exercise | +2,560 | 2,560 | ||
| 2026-06-15 | Zurbay Donald Director | Shares withheld for taxes | −308 | $79.70 | $25K | 2,252 |
| 2026-06-15 | Zurbay Donald Director | Option exercise · Restricted Stock Units | −2,560 | 0 | ||
| 2026-06-15 | Zurbay Donald Director | Grant or award · Restricted Stock Units | +2,383 | 2,383 | ||
| 2026-05-26 | Bianchi Francesco Director | Sale | −1,800 | $75.75 | $136K | 7,228 |
| 2026-03-30 | Tezel Ahmet Chief Innovation Officer | Option exercise | +3,408 | 5,343 | ||
| 2026-03-30 | Tezel Ahmet Chief Innovation Officer | Shares withheld for taxes | −1,186 | $61.27 | $73K | 4,157 |
| 2026-03-30 | Tezel Ahmet Chief Innovation Officer | Option exercise · Restricted Stock Units | −3,408 | 6,814 | ||
| 2026-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Restricted Stock Units | +13,873 | 13,873 | ||
| 2026-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Performance Stock Units | +4,624 | 4,624 | ||
| 2026-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Performance Stock Units | +4,624 | 4,624 | ||
| 2026-03-30 | Tezel Ahmet Chief Innovation Officer | Grant or award · Performance Stock Units | +4,624 | 4,624 | ||
| 2026-03-30 | Poletti Franco President, Cardiopulmonary | Option exercise | +3,184 | 12,125 |
Page 3 of 25 · 489 trades